Patent Foramen Ovale (PFO) and Risk of Perioperative Stroke

NCT ID: NCT05592301

Last Updated: 2023-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

408 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-07

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-centre, prospective cohort study to determine if asymptomatic PFO is a risk factor for developing perioperative overt and covert stroke in patients undergoing non-cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is emerging evidence regarding the increased risk of perioperative stroke in patients with PFO, leading to an important clinical practice question: whether PFO should be considered in the perioperative risk assessment in non-cardiac surgery patients. The evidence base, however, comes from retrospective studies with numerous limitations.

Patients referred for general, orthopedic, urological, gynecologic, spinal, or thoracic surgery will be screened and consented during the surgery pre-admission clinic visit, and then undergo PFO screening using transcranial Doppler (TCD) and transthoracic echocardiography (TTE). Patients screened PFO+ (n=102) and matched PFO- controls (n=102) will have DW-MRI between postoperative days 2 and 7. Study personnel will conduct phone surveys at 30-day and 1-year post-surgery to collect data on other clinical outcomes. Patients will also be administered cognitive and patient-reported outcome measures assessments before enrollment, and 30-day and 1-year follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patent Foramen Ovale

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgical patients

Patients undergoing major non-cardiac, non-vascular, and non-brain surgery who will be examined for a presence of PFO

Diffusion-weighted Magnetic Resonance Imaging (DW-MRI)

Intervention Type DIAGNOSTIC_TEST

The Diffusion-weighted Magnetic Resonance Imaging (DW-MRI) is used to diagnose perioperative stroke.

Transcranial Doppler (TCD)

Intervention Type DIAGNOSTIC_TEST

Used to diagnose PFO

Transthoracic Echocardiogram (TTE)

Intervention Type DIAGNOSTIC_TEST

Used to diagnose PFO.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diffusion-weighted Magnetic Resonance Imaging (DW-MRI)

The Diffusion-weighted Magnetic Resonance Imaging (DW-MRI) is used to diagnose perioperative stroke.

Intervention Type DIAGNOSTIC_TEST

Transcranial Doppler (TCD)

Used to diagnose PFO

Intervention Type DIAGNOSTIC_TEST

Transthoracic Echocardiogram (TTE)

Used to diagnose PFO.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. patients 18 years and above;
2. referred for an elective, non-cardiac, non-vascular and non-brain surgery;
3. with an estimated hospital length of stay ≥2 days. We will include patients referred for general, orthopedic, urological, gynecologic, spinal or thoracic surgery.

Exclusion Criteria

1. patients in need for long-term, perioperative anticoagulants;
2. those with comorbidities that potentially increase the risk of perioperative stroke;
3. contraindications to MRI;
4. unable to complete or adhere to the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

110 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peter Munk Cardiac Centre

UNKNOWN

Sponsor Role collaborator

University Health Network, Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eric Horlick

Director, Structural Heart Disease

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric Horlick, MD

Role: PRINCIPAL_INVESTIGATOR

University Health Network, Peter Munk Cardiac Centre

Lusine Abrahamyan, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Health Network, Theta Collaborative

Aleksandra Pikula, MD

Role: PRINCIPAL_INVESTIGATOR

University Heath Network, Division of Neurology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Toronto General Hospital, UHN

Toronto, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lusine Abrahamyan, MD, PhD

Role: CONTACT

416-340-4800

Eric Horlick, MD

Role: CONTACT

416-340-3835

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lusine Abrahamyan, MD

Role: primary

416-340-4800

References

Explore related publications, articles, or registry entries linked to this study.

Hobbes B, Akseer S, Pikula A, Huszti E, Devereaux PJ, Horlick E, Abrahamyan L. Risk of Perioperative Stroke in Patients With Patent Foramen Ovale: A Systematic Review and Meta-analysis. Can J Cardiol. 2022 Aug;38(8):1189-1200. doi: 10.1016/j.cjca.2022.02.026. Epub 2022 Mar 3.

Reference Type BACKGROUND
PMID: 35247468 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAPPRES

Identifier Type: OTHER

Identifier Source: secondary_id

21-5671

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Prediction of Atherosclerotic Plaque Progression
NCT05424705 ACTIVE_NOT_RECRUITING